ROSSI, GEMMA
ROSSI, GEMMA
Medicina Sperimentale e Clinica
Correlation Between Tumor Response and Survival Outcomes in Patients with Advanced Gastric Cancer Receiving Ramucirumab and Paclitaxel as Second-Line Therapy
2022 Roviello, Giandomenico; Martina, Catalano; Winchler, Costanza; De Gennaro Aquino, Irene; Papa, Francesca; Buttitta, Eleonora; Rossi, Gemma; Antonuzzo, Lorenzo
Current status and future perspectives in HER2 positive advanced gastric cancer
2022 Roviello, G; Catalano, M; Iannone, L F; Marano, L; Brugia, M; Rossi, G; Aprile, G; Antonuzzo, L
Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions
2022 Lavacchi, Daniele; Caliman, Enrico; Rossi, Gemma; Buttitta, Eleonora; Botteri, Cristina; Fancelli, Sara; Pellegrini, Elisa; Roviello, Giandomenico; Pillozzi, Serena; Antonuzzo, Lorenzo
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer
2023 Cosso, Federica; Lavacchi, Daniele; Fancelli, Sara; Caliman, Enrico; Brugia, Marco; Rossi, Gemma; Winchler, Costanza; Pillozzi, Serena; Antonuzzo, Lorenzo
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer
2022 Lavacchi, Daniele; Fancelli, Sara; Roviello, Giandomenico; Castiglione, Francesca; Caliman, Enrico; Rossi, Gemma; Venturini, Jacopo; Pellegrini, Elisa; Brugia, Marco; Vannini, Agnese; Bartoli, Caterina; Cianchi, Fabio; Pillozzi, Serena; Antonuzzo, Lorenzo
Occurrence of Dysgeusia in Patients Being Treated for Cancer
2022 Di Meglio, Jaclyn; Dinu, Monica; Doni, Laura; Rossi, Gemma; Giorgione, Roberta; Colombini, Barbara; Antonuzzo, Lorenzo; Sofi, Francesco
The emerging role of immunotherapy in biliary tract cancer: a review of new evidence and predictive biomarkers
2022 Giorgione, Roberta; Risaliti, Matteo; Bartolini, Ilenia; Rossi, Gemma; Pillozzi, Serena; Muiesan, Paolo; Taddei, Antonio; Antonuzzo, Lorenzo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Correlation Between Tumor Response and Survival Outcomes in Patients with Advanced Gastric Cancer Receiving Ramucirumab and Paclitaxel as Second-Line Therapy | 2022 | Roviello, Giandomenico; Martina, Catalano; Winchler, Costanza; De Gennaro Aquino, Irene; Papa, Francesca; Buttitta, Eleonora; Rossi, Gemma; Antonuzzo, Lorenzo | |
| Current status and future perspectives in HER2 positive advanced gastric cancer | 2022 | Roviello, G; Catalano, M; Iannone, L F; Marano, L; Brugia, M; Rossi, G; Aprile, G; Antonuzzo, L | |
| Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions | 2022 | Lavacchi, Daniele; Caliman, Enrico; Rossi, Gemma; Buttitta, Eleonora; Botteri, Cristina; Fancelli, Sara; Pellegrini, Elisa; Roviello, Giandomenico; Pillozzi, Serena; Antonuzzo, Lorenzo | |
| Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer | 2023 | Cosso, Federica; Lavacchi, Daniele; Fancelli, Sara; Caliman, Enrico; Brugia, Marco; Rossi, Gemma; Winchler, Costanza; Pillozzi, Serena; Antonuzzo, Lorenzo | |
| Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer | 2022 | Lavacchi, Daniele; Fancelli, Sara; Roviello, Giandomenico; Castiglione, Francesca; Caliman, Enrico; Rossi, Gemma; Venturini, Jacopo; Pellegrini, Elisa; Brugia, Marco; Vannini, Agnese; Bartoli, Caterina; Cianchi, Fabio; Pillozzi, Serena; Antonuzzo, Lorenzo | |
| Occurrence of Dysgeusia in Patients Being Treated for Cancer | 2022 | Di Meglio, Jaclyn; Dinu, Monica; Doni, Laura; Rossi, Gemma; Giorgione, Roberta; Colombini, Barbara; Antonuzzo, Lorenzo; Sofi, Francesco | |
| The emerging role of immunotherapy in biliary tract cancer: a review of new evidence and predictive biomarkers | 2022 | Giorgione, Roberta; Risaliti, Matteo; Bartolini, Ilenia; Rossi, Gemma; Pillozzi, Serena; Muiesan, Paolo; Taddei, Antonio; Antonuzzo, Lorenzo |